This is a translation of the original article in Portuguese. Read the original (Português).
A large scientific review has placed escitalopram first in a comparison of 20 antidepressants. The study, by researchers at Radboud University Medical Center in the Netherlands, was published in the journal The Lancet Psychiatry and analyzed more than 115 studies that together include about 30,000 patients, according to the British newspaper Daily Mail.
In the ranking, escitalopram appears ahead of sertraline and Prozac, the brand name for fluoxetine. The medications evaluated are among the most widely used antidepressants.
The authors themselves make an important caveat: the results are population averages. That means the ranking describes what tends to happen in a large group of people, not what will happen to each individual patient. Someone who responds well to a drug further down the list has no reason, based on this study alone, to think their treatment is wrong.
For that reason, the researchers state that no one should switch medication on their own. Changing antidepressants usually requires evaluation and follow-up by a doctor, who considers the person’s history, their response to the current treatment, and other individual factors.
The topic carries weight in Brazil. Escitalopram and sertraline are common in the country, including in the Unified Health System (SUS), and antidepressants are among the medications most used by professionals exposed to intense stress. For those already taking one of them, the guidance that accompanies the study is to talk to a doctor before making any decision, without stopping or swapping the medication on their own initiative.
In practice, the ranking serves as another reference for science and clinical practice, helping to compare treatments on a large scale. It does not replace case-by-case assessment, which remains what determines which medication is most suitable for each person.
Reporting from Daily Mail (p. 36 (Países Baixos)).
Deixe um comentário